1. FRI0692 Anti-tnf treatments for women with chronic inflammatory diseases: comparing attitudes and perceptions of physicians in europe and the us. (12th June 2018) Authors: Tincani, A.; Taylor, P.; Fischer-Betz, R.; Ecoffet, C.; Chakravarty, E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0693 Fears and misconceptions of women with chronic rheumatic diseases on their journey to motherhood. (12th June 2018) Authors: Tincani, A.; Taylor, P.; Fischer-Betz, R.; Ecoffet, C.; Chakravarty, E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 866 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2). (1st April 2021) Authors: Gordon, K.B.; Warren, R.B.; Gottlieb, A.B.; Blauvelt, A.; Thaçi, D.; Leonardi, C.; Poulin, Y.; Boehnlein, M.; Brock, F.; Ecoffet, C.; Reich, K. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3‐year results from two randomized phase III trials (CIMPASI‐1 and CIMPASI‐2). (9th September 2020) Authors: Gordon, K.B.; Warren, R.B.; Gottlieb, A.B.; Blauvelt, A.; Thaçi, D.; Leonardi, C.; Poulin, Y.; Boehnlein, M.; Brock, F.; Ecoffet, C.; Reich, K. Journal: British journal of dermatology Issue: Volume 184:Number 4(2021) Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0227 A Randomized Double-Blind Treatment Strategy Study Evaluating Continuation or Reduced-Frequency Dosing of Certolizumab Pegol versus Withdrawal To Maintain Low Disease Activity in Early RA Patients (C-Early Period 2). (15th July 2016) Authors: Emery, P.; Bingham, C.; Burmester, G.-R.; Bykerk, V.P.; Furst, D.; Mariette, X.; van der Heijde, D.; van Vollenhoven, R.; VanLunen, B.; Ecoffet, C.; Cioffi, C.; Weinblatt, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0331-HPR BARRIERS TO SHARED DECISION-MAKING WITH WOMEN OF REPRODUCTIVE AGE AFFECTED BY CHRONIC INFLAMMATORY DISEASES. (2nd June 2020) Authors: Murray, S.; Fischer-Betz, R.; Augustyniak, M.; Murase, J.; Nelson-Piercy, C.; Vlaev, I.; Ecoffet, C.; Peniuta, M.; Jenkins, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0242 Pregnancy outcomes and disease activity in women with axial spondyloarthritis: a systematic literature review. (12th June 2018) Authors: Moltó, A.; Gensler, L.; Clowse, M.E.B.; Marzo-Ortega, H.; Artignan, A.; Goff-Leggett, D.; Leonard, S.; Resemann, H.K.; Thurtle, E.; de Peyrecave, N.; Ecoffet, C.; Förger, F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗